Literature DB >> 8187441

Von Willebrand factor antigen in assessment of vasculitis in patients with connective tissue diseases.

J Kloczko1, A Kuryliszyn-Moskal, K Bernacka, M Bielawiec, B Cylwik, P Radziwon.   

Abstract

Von Willebrand factor antigen (vWF:Ag) is synthesized and secreted by endothelial cells. In the present study we tried to assess the relationship between plasma level of vWF:Ag and vascular damage in patients with vasculitis. The study was carried out on 59 patients with connective tissue diseases. Vasculitis was diagnosed by biopsies of the skin. The patients with vasculitis had a significantly elevated level of vWF:Ag; however, no significant correlation between the amount of plasma vWF:Ag and the degree of vasculitis was found. The obtained results show that the plasma level of vWF:Ag may reflect the presence of vascular, especially endothelial, damage in patients with connective tissue diseases.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8187441     DOI： 10.1007/bf02229862

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   2.980


  16 in total

1.  Behaviour of von Willebrand factor antigen in follow-up of polymyalgia rheumatica/giant cell arteritis.

Authors:  M L Ciompi; G Marotta; L Puccetti; E Remorini; G Petrini; M Zuccotti; M Vispi; U Baicchi; P Iacconi
Journal:  Scand J Rheumatol       Date:  1988       Impact factor: 3.641

2.  An increased factor VIII antigen as an indicator of endothelial damage in measles.

Authors:  R Corda; M Alberti; L Caocci; G Putzolu; P M Mannucci
Journal:  Thromb Res       Date:  1979       Impact factor: 3.944

3.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.

Authors:  F C Arnett; S M Edworthy; D A Bloch; D J McShane; J F Fries; N S Cooper; L A Healey; S R Kaplan; M H Liang; H S Luthra
Journal:  Arthritis Rheum       Date:  1988-03

4.  Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies.

Authors:  C B Laurell
Journal:  Anal Biochem       Date:  1966-04       Impact factor: 3.365

5.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.

Authors: 
Journal:  Arthritis Rheum       Date:  1980-05

6.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11

7.  Synthesis of antihemophilic factor antigen by cultured human endothelial cells.

Authors:  E A Jaffe; L W Hoyer; R L Nachman
Journal:  J Clin Invest       Date:  1973-11       Impact factor: 14.808

8.  The clinical significance of coagulation abnormalities in systemic sclerosis (scleroderma).

Authors:  P Lee; C S Norman; S Sukenik; C A Alderdice
Journal:  J Rheumatol       Date:  1985-06       Impact factor: 4.666

9.  Significance of increased factor VIII in early glomerulonephritis.

Authors:  M R Ekberg; I M Nilsson; F Linell
Journal:  Ann Intern Med       Date:  1975-09       Impact factor: 25.391

10.  Increased factor VIII/von Willebrand factor antigen and von Willebrand factor activity in scleroderma and in Raynaud's phenomenon.

Authors:  M B Kahaleh; I Osborn; E C LeRoy
Journal:  Ann Intern Med       Date:  1981-04       Impact factor: 25.391
View more
  1 in total

1.  Plasma concentration of selected biochemical markers of endothelial dysfunction in women with various severity of chronic venous insufficiency (CVI)-A pilot study.

Authors:  Magdalena Budzyń; Maria Iskra; Wojciech Turkiewicz; Zbigniew Krasiński; Bogna Gryszczyńska; Magdalena Paulina Kasprzak
Journal:  PLoS One       Date:  2018-01-29       Impact factor: 3.240
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.